EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Enhancing the treat-to-target approach of inflammatory arthritis with purposeful shared decision-making: results of a randomized controlled trial

Yasser El Miedany, Maha Elgaafary, Susan Plummer, Sami Bahlas, Safaa Mahran, Deborah Palmer, Waleed Hassan, Walaa Elwakil, Ali El Miedany

Clinical Rheumatology · 2026-08 · 45 (8) · 4845-4853

DOI: 10.1007/s10067-026-08229-1 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Rheumatology, online erschienen am 28.06.2026. Verfasst von Yasser El Miedany und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Rehabilitation, Canterbury Christ Church University, England, UK. yasserelmiedany@gmail.com. Hauptthemen laut MEDLINE: Decision Making, Shared, Patient Participation, Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Purposeful SDM (PSDM) is a problem-based approach that emphasizes the multifaceted nature of SDM in response to different settings and contexts.

Objective

To evaluate the effectiveness of a novel approach utilizing patient decision aids in facilitating purposeful shared decision-making within the context of rheumatology care. Methodology This randomized controlled study included 431 patients diagnosed with inflammatory arthritis. The patients were randomized to receive management according to either the traditional standard care protocol (215 patients) or the purposeful shared decision-making (PSDM) approach (216 patients), which utilizes structured communication tools. At the end of 1 year of intensive therapy, 6 key outcomes were be assessed to measure the impact of PSDM: clinical remission, medication adherence, treatment cessation, patient motivation, multidisciplinary engagement (contact and utilization rates of the helpline facility), and comprehensibility.

Results

At 12 months of treatment, 84.3% of the PSDM group achieved treatment target scores, which was significantly higher than the control group, where 62.3% achieved the target. The patients’ adherence to anti-rheumatic therapy, as well as comprehensibility, was significantly higher ( p < 0.1) in the PSDM group in comparison to the control group ( p < 0.01). Patient motivation scores were significantly higher in the PSDM group ( p < 0.01). The percentage of patients who contacted the help line from the control group was significantly higher, in contrast to the PSDM group ( p < 0.01).

Conclusion

Using rheumatology-specific PSDM tools aids in improving patients’ knowledge and supporting communication with their clinicians on treatment benefits and risks. PSDM strategies may improve implementation of the treat-to-target approach. Addressing the variable modes of shared decision-making beyond weighing treatment options improves patients’ understanding of the disease. Key Points • Shared decision-making (SDM), a collaborative process where clinicians and patients jointly arrive at meaningful healthcare decisions. • Purposeful Shared Decision-Making (PSDM) is a problem-based approach that acknowledges the multifaceted nature of SDM, adapting its application to diverse settings, patient needs, and decision types. • A PSDM framework, supported by patient decision aids, demonstrably improves critical outcomes in patients with inflammatory arthritis and spondyloarthritis. • By fostering deeper patient understanding, increasing adherence, boosting motivation, and reducing reliance on external support, PSDM facilitates better disease control and patient empowerment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Making, SharedPatient ParticipationAntirheumatic AgentsArthritis, RheumatoidArthritisHumansFemaleMaleMiddle AgedAdultMedication AdherenceMotivationAdherence InterventionsTreatment Outcome

Stichwörter der Autor:innen

AdherenceComprehensibilityPatient motivationPsAPurposeful shared decision-makingRASpA

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Rheumatology and Rehabilitation, Canterbury Christ Church University, England, UK. yasserelmiedany@gmail.com.
  • Rheumatology and Rehabilitation Department, Ain Shams University, Cairo, Egypt. yasserelmiedany@gmail.com.
  • Community and Public Health, Ain Shams University, Cairo, Egypt.
  • Institute of Medical Science, Canterbury Christ Church University, England, UK.
  • King Abdulaziz University, Jeddah, Saudi Arabia.
  • Rheumatology, Rehabilitation and Physical Medicine, Assiut University, Assiut, Egypt.

Zitieren

APA

El Miedany, Y., Elgaafary, M., Plummer, S., Bahlas, S., Mahran, S., Palmer, D., Hassan, W., Elwakil, W., & El Miedany, A. (2026). Enhancing the treat-to-target approach of inflammatory arthritis with purposeful shared decision-making: results of a randomized controlled trial. Clinical Rheumatology, 45(8), 4845-4853. https://doi.org/10.1007/s10067-026-08229-1

Vancouver

El Miedany Y, Elgaafary M, Plummer S, Bahlas S, Mahran S, Palmer D, et al. Enhancing the treat-to-target approach of inflammatory arthritis with purposeful shared decision-making: results of a randomized controlled trial. Clinical Rheumatology. 2026;45(8):4845-4853. doi:10.1007/s10067-026-08229-1

BibTeX
@article{ElMiedany2026,
  author = {El Miedany, Yasser and Elgaafary, Maha and Plummer, Susan and Bahlas, Sami and Mahran, Safaa and Palmer, Deborah and Hassan, Waleed and Elwakil, Walaa and El Miedany, Ali},
  title = {Enhancing the treat-to-target approach of inflammatory arthritis with purposeful shared decision-making: results of a randomized controlled trial},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {8},
  pages = {4845--4853},
  doi = {10.1007/s10067-026-08229-1}
}
Kostenlos starten →